| 754 |
Centers for Disease Control and Prevention |
Html |
en |
Preventing Chronic Disease | Trends in Tobacco Smoke Exposure and Blood Lead Levels Among Youths and Adults in the United States: The National Health and Nutrition Examination Survey, 1999"2008 - CDC |
Tobacco smoke is a source of exposure to thousands of toxic chemicals including lead, a chemical of longstanding public health concern. We assessed trends in blood lead levels in youths and adults with cotinine-verified tobacco smoke exposure by using 10 years of data from the National Health and Nutrition Examination Survey. |
| Second-hand smoke exposure | 0.511938 |
| government-defined poverty threshold | 0.519892 |
| United States | 0.590733 |
| Blood Lead Epidemiology | 0.481975 |
| self-reported nonsmokers | 0.474839 |
| relevant financial relationships | 0.4883 |
| adults | 0.471556 |
| unexposed nonsmokers | 0.473104 |
| low-level lead exposure | 0.517626 |
| smokers | 0.493366 |
| occupational exposure | 0.490266 |
| exposure groups | 0.48649 |
| Adult Blood Lead | 0.486322 |
| MMWR Morb Mortal | 0.472217 |
| NHANES job categories | 0.510419 |
| Patricia A. Richter | 0.489024 |
| Disease Control | 0.589975 |
| higher exposure | 0.508049 |
| lead exposure jobs | 0.526585 |
| smoking | 0.487163 |
| public health concern | 0.508045 |
| smoke exposure | 0.778028 |
| Nutrition Examination Survey | 0.573004 |
| public health | 0.556515 |
|
| smoke exposure level | 0.541591 |
| Morb Mortal Wkly | 0.472216 |
| poverty threshold | 0.616788 |
| higher SHS exposure | 0.717653 |
| lower exposure | 0.505153 |
| secondhand smoke exposure | 0.570241 |
| cotinine-verified tobacco smoke | 0.49545 |
| higher BLLs | 0.484316 |
| Consumer Price Index | 0.51526 |
| BLLs | 0.510413 |
| National Health | 0.531083 |
| Chronic Disease Prevention | 0.481409 |
| SHS exposure | 0.931938 |
| in-home lead exposure | 0.51561 |
| Ellen E. Bishop | 0.490878 |
| nonsmokers | 0.572703 |
| involuntary exposure | 0.482118 |
| environmental exposure | 0.479837 |
| tobacco smoke exposure | 0.72362 |
| lower SHS exposure | 0.668943 |
| higher mean BLLs | 0.482875 |
| lead exposure | 0.610361 |
| blood lead levels | 0.840188 |
|
CLICK HERE |
| 941 |
Centers for Disease Control and Prevention |
Html |
en |
Highlights: Minors' Access to Tobacco |
CDC's Office on Smoking and Health offers information related to smoking and tobacco use. |
| MPEG | 0.378858 |
| search | 0.263099 |
| PDF | 0.261307 |
| PPT | 0.446092 |
|
| DOC | 0.368812 |
| information | 0.262482 |
| different file formats | 0.938484 |
| page | 0.276773 |
|
CLICK HERE |
| 6195 |
Centers for Disease Control and Prevention |
Html |
en |
Predictors of repeated PSA testing among black and white men from the Maryland Cancer Survey, 2006. |
null |
| recent PSA test | 0.366462 |
| high-risk prostate cancer | 0.283254 |
| health insurance | 0.345875 |
| Self-reported repeated PSA | 0.408098 |
| PSA testing | 0.991583 |
| PSA velocity | 0.415372 |
| single PSA concentration | 0.345023 |
| initial PSA measurement | 0.324966 |
| blacks | 0.292815 |
| prostate cancer detection | 0.283247 |
| whites | 0.281049 |
| National Comprehensive Cancer | 0.271725 |
| white men | 0.326189 |
| PSA tests | 0.45312 |
| single PSA | 0.363914 |
| telephone numbers | 0.266629 |
| serum PSA | 0.356659 |
| Maryland Cancer Survey | 0.287342 |
| age groups | 0.274896 |
| Cancer Network guidelines | 0.271594 |
| prostate cancer aggressiveness | 0.283481 |
| PSA test | 0.552332 |
| Comprehensive Cancer Network | 0.272417 |
| PSA concentration | 0.364038 |
| prostate cancer testing | 0.300163 |
|
| United States | 0.27096 |
| age group | 0.29225 |
| individual PSA screening | 0.353788 |
| repeated PSA testing | 0.379858 |
| PSA level | 0.364857 |
| cancer screening rates | 0.270973 |
| men | 0.425021 |
| self-reported PSA testing | 0.365916 |
| PSA screening | 0.356288 |
| health care | 0.348207 |
| black men | 0.356089 |
| race | 0.301558 |
| prostate cancer screening | 0.363932 |
| initial PSA testing | 0.350402 |
| high PSA velocity | 0.347289 |
| prostate cancer | 0.888705 |
| higher proportion | 0.26593 |
| family history | 0.372093 |
| repeat PSA testing | 0.351782 |
| PSA question | 0.324863 |
| serum PSA levels | 0.348273 |
| Cancer Screening Trial | 0.272204 |
| single PSA measurement | 0.360623 |
| low PSA concentrations | 0.347884 |
|
CLICK HERE |
| 6331 |
Centers for Disease Control and Prevention |
Html |
en |
Using the community readiness model to select communities for a community-wide obesity prevention intervention. |
null |
| Community Psychol | 0.272018 |
| obesity prevention program | 0.251608 |
| broad community participation | 0.255906 |
| address childhood obesity | 0.264074 |
| community coalition | 0.276998 |
| M. Community readiness | 0.302024 |
| community decision makers | 0.290239 |
| community-based obesity research | 0.273633 |
| community knowledge | 0.29135 |
| obesity prevention programs | 0.28946 |
| community climate | 0.38622 |
| study team | 0.493045 |
| community efforts | 0.30993 |
| obesity prevention | 0.652413 |
| food service | 0.358569 |
| childhood obesity prevention | 0.58477 |
| obesity prevention intervention | 0.31412 |
| obesity interventions | 0.259012 |
| community readiness | 0.675599 |
| obesity prevention efforts | 0.286276 |
| school food service | 0.287292 |
| community | 0.828785 |
| efforts | 0.317263 |
| randomized community intervention | 0.259592 |
| Overall readiness scores | 0.280487 |
|
| community readiness key | 0.306536 |
| school district | 0.255046 |
| CRM | 0.303086 |
| community members | 0.28405 |
| community leaders | 0.29728 |
| obesity prevention model | 0.280922 |
| comprehensive obesity prevention | 0.261846 |
| Community Readiness Survey | 0.304229 |
| overall readiness score | 0.317315 |
| CRM protocol | 0.284676 |
| childhood obesity issue | 0.276096 |
| community readiness model | 0.544671 |
| L. Community readiness | 0.30577 |
| community-based obesity prevention | 0.375962 |
| childhood obesity intervention | 0.303074 |
| community prevention coalitions | 0.246755 |
| community readiness measure | 0.311644 |
| community capacity | 0.272587 |
| physical activity | 0.31371 |
| mean readiness score | 0.287508 |
| food service director | 0.274333 |
| multilevel community interventions | 0.275298 |
| childhood obesity | 0.968163 |
| community coalition representative | 0.256705 |
|
CLICK HERE |
| 7043 |
Centers for Disease Control and Prevention |
Html |
en |
Work-Related Asthma - 38 States and District of Columbia, 2006-2009 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| work-exacerbated asthma | 0.60086 |
| occupational asthma | 0.605161 |
| current asthma prevalence | 0.661665 |
| WRA range | 0.630927 |
| ACBS participants | 0.511611 |
| Risk Factor Surveillance | 0.476019 |
| estimated proportion | 0.488259 |
| health risk behaviors | 0.484755 |
| WRA diagnosis | 0.674996 |
| adult asthma | 0.568565 |
| asthma care | 0.583385 |
| severe asthma | 0.560656 |
| national health agencies | 0.487151 |
| current asthma | 0.949653 |
| BRFSS | 0.517781 |
| similar occupational exposures | 0.486921 |
| new onset asthma | 0.638144 |
| occupation information | 0.486847 |
| annual average | 0.54424 |
| asthma morbidity | 0.569303 |
| WRA prevalence | 0.638084 |
| WRA respondents | 0.633617 |
| proportion | 0.521608 |
| ever-employed adults | 0.584609 |
| United States | 0.478076 |
|
| WRA | 0.902497 |
| WRA epidemiology | 0.613885 |
| preventive health practices | 0.484725 |
| work-related asthma | 0.705842 |
| states | 0.546174 |
| concurrent asthma | 0.599312 |
| preventable occupational lung | 0.481373 |
| BRFSS respondents | 0.484696 |
| state asthma programs | 0.597575 |
| estimated annual average | 0.491515 |
| expanded WRA surveillance.** | 0.644904 |
| WRA management | 0.626341 |
| random-digit–dialed telephone survey | 0.47654 |
| BRFSS completion date | 0.48268 |
| BRFSS state coordinators | 0.477108 |
| health | 0.524666 |
| Gretchen E. Knoeller | 0.521599 |
| ACBS | 0.650735 |
| American Thoracic Society | 0.477722 |
| WRA cases | 0.713398 |
| asthma symptoms | 0.611736 |
| information | 0.505827 |
| WRA surveillance | 0.654288 |
| Asthma Call-Back Survey | 0.621432 |
|
CLICK HERE |
| 7550 |
Centers for Disease Control and Prevention |
Html |
en |
Update on Vaccine-Derived Polioviruses - Worldwide, April2011-June 2012 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| genetically distinct aVDPV2s | 0.58483 |
| sewage samples | 0.765584 |
| corresponding OPV strain | 0.604366 |
| genetically related VDPV | 0.537846 |
| unvaccinated AFP patients | 0.623889 |
| oral poliovirus vaccine | 0.559333 |
| poliovirus serotypes | 0.564196 |
| highly divergent aVDPV2s | 0.602431 |
| AFP | 0.92699 |
| Polio Laboratory Network | 0.605627 |
| AFP patients | 0.77479 |
| low poliovirus vaccine | 0.639061 |
| AFP cases | 0.597464 |
| prolonged iVDPV infections | 0.64319 |
| poliovirus vaccination coverage | 0.539178 |
| vaccination coverage | 0.66973 |
| OPV | 0.703481 |
| primary immunodeficiency | 0.654611 |
| VDPV circulation | 0.611944 |
| OPV coverage | 0.585097 |
| iVDPV infections | 0.648363 |
| polio vaccination coverage | 0.588852 |
| middle-income countries | 0.577541 |
|
| World Health Organization | 0.730505 |
| VDPVs | 0.705889 |
| genetically related VDPVs | 0.527278 |
| divergent aVDPVs | 0.572075 |
| immunologically normal OPV | 0.544599 |
| inactivated poliovirus vaccine | 0.588075 |
| poliovirus vaccine coverage | 0.691586 |
| high poliovirus vaccine | 0.532867 |
| common variable immunodeficiency | 0.637255 |
| severe combined immunodeficiency | 0.539073 |
| low OPV coverage | 0.57622 |
| persons | 0.634684 |
| AFP patient | 0.818899 |
| primary immunodeficiencies | 0.69924 |
| global poliovirus surveillance | 0.531367 |
| high OPV coverage | 0.540259 |
| newly identified persons | 0.548551 |
| insensitive AFP surveillance | 0.620634 |
| Global Polio Laboratory | 0.603898 |
| previously reported VDPV | 0.535164 |
| high vaccination coverage | 0.61824 |
| polio eradication efforts | 0.529512 |
| highly divergent aVDPV2 | 0.609456 |
|
CLICK HERE |
| 8288 |
Centers for Disease Control and Prevention |
Html |
en |
Mobile Device Use While Driving - United States and SevenEuropean Countries, 2011 |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| EuroPNStyles survey respondents | 0.291163 |
| Alternate Text | 0.288552 |
| representative telephone survey | 0.267709 |
| public relations firm | 0.267084 |
| mobile communication technologies | 0.36583 |
| recent national estimates | 0.266344 |
| risky driving behaviors | 0.354089 |
| road traffic crashes | 0.371217 |
| Rebecca B. Naumann | 0.308606 |
| similar survey methods | 0.270911 |
| Ñ?ЛП
Road traffic | 0.269736 |
| alcohol-impaired driving | 0.311606 |
| U.S. adult drivers | 0.268111 |
| percentages | 0.315638 |
| countries | 0.325434 |
| significantly larger percentage | 0.306214 |
| worldwide social marketing | 0.266362 |
| text message | 0.338844 |
| global public health | 0.317808 |
| weighted percentage | 0.367568 |
| cell phone capabilities | 0.287894 |
| drivers | 0.293068 |
| United States | 0.790601 |
| phone use laws | 0.287373 |
| age group | 0.283913 |
|
| differences | 0.274409 |
| phone technological advances | 0.271149 |
| Response choices | 0.415985 |
| fall HealthStyles survey | 0.415922 |
| cell phone | 0.95477 |
| public education campaigns | 0.35906 |
| prevalence estimates | 0.267009 |
| prevalence | 0.297523 |
| HealthStyles data analyzed | 0.276819 |
| high-visibility enforcement | 0.301455 |
| seat belt nonuse | 0.36212 |
| injury prevention | 0.291031 |
| e-mail messages | 0.542365 |
| cell phones | 0.272791 |
| HealthStyles survey data | 0.286202 |
| Population Survey proportions | 0.272251 |
| spring HealthStyles survey | 0.395115 |
| United Kingdom | 0.271437 |
| self-reported mobile device | 0.275568 |
| distracted driving–related crashes | 0.268938 |
| mobile device | 0.625597 |
| public health problem | 0.317804 |
| HealthStyles survey responses | 0.27865 |
| HealthStyles survey | 0.459228 |
|
CLICK HERE |
| 12579 |
Centers for Disease Control and Prevention |
Video |
en |
Ebola PSA from First Lady of Guinea, Hadja Djene Kaba Condé (in French) |
(In French) The First Lady of Guinea, Hadja Djene Kaba Condé, delivers a PSA about Ebola. Washing hands well can help protect yourself and your family from Ebola and also other diseases. Ebola is a very serious disease. But it is possible to survive and heal with proper medical treatment. If you or someone you know thinks he has the disease, go to the hospital immediately for treatment.
Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html
This video can also be viewed at
http://www.cdc.gov/vhf/ebola/resources/videos/ebola-first-lady-guinea-psa.mp4 |
| Djene Kaba Condé | 0.99122 |
| Guinea | 0.33821 |
| Hadja | 0.216911 |
|
| YouTube | 0.351326 |
| Lady | 0.217424 |
|
CLICK HERE |
| 13857 |
Centers for Disease Control and Prevention |
Html |
en |
Infertility | Reproductive Health | CDC |
Reproductive Health |
| sperm production | 0.524783 |
| semen analysis | 0.600885 |
| health care provider | 0.642338 |
| specially prepared sperm | 0.517308 |
| ovarian function | 0.64747 |
| normal ovarian function | 0.520943 |
| uterus | 0.600039 |
| different infertility diagnoses | 0.561213 |
| benign pituitary gland | 0.615344 |
| Intracytoplasmic sperm injection | 0.516168 |
| Assisted Reproductive Technology | 0.599488 |
| reproductive technology | 0.677721 |
| pituitary gland tumor | 0.615234 |
| pituitary glands | 0.600955 |
| ovarian reserve | 0.578814 |
| couples | 0.519787 |
| success rates | 0.616472 |
| ovulation predictor kit | 0.523723 |
| certain types | 0.52251 |
| menstrual cycle | 0.565895 |
| reproductive endocrinologist—a doctor | 0.522812 |
| infertility issues | 0.52809 |
| women | 0.819523 |
| woman | 0.823633 |
|
| United States | 0.651925 |
| intrauterine insemination | 0.531801 |
| art success rates | 0.569109 |
| donor sperm | 0.545917 |
| pituitary gland | 0.763439 |
| male factor infertility | 0.723679 |
| polycystic ovary syndrome | 0.671612 |
| mature eggs | 0.599725 |
| fallopian tube | 0.59554 |
| American Urological Association | 0.602271 |
| improper function | 0.542096 |
| infertility treatment | 0.568704 |
| donor eggs | 0.560118 |
| sperm | 0.589989 |
| infertility | 0.98944 |
| male infertility | 0.573787 |
| National Infertility Association | 0.567182 |
| unexplained infertility | 0.529668 |
| vitro fertilization | 0.596286 |
| female infertility | 0.635849 |
| infertility diagnosis | 0.526698 |
| fallopian tubes | 0.643233 |
| ART procedures | 0.540437 |
| age | 0.544828 |
|
CLICK HERE |
| 15657 |
Centers for Disease Control and Prevention |
Html |
null |
Cases in Pregnant Women |
Information on Zika virus. Provided by the U.S. Centers for Disease Control and Prevention. |
|
|
CLICK HERE |